What is PharmaMar?
[[Image:Pharma Mar logo.svg|right|200px]] '''PharmaMar''' is a pharmaceutical company based in [[Madrid]], [[Spain]]. It uses marine resources to develop drugs for cancer and Alzheimer's treatments. It is also involved in molecular testing, including COVID-19 testing, and genetic analysis. Its subsidiary, Sylentis, develops therapies that use RNA interference.<ref>{{Cite news|date=2015-02-26|title=BRIEF-Zeltia to propose reverse merger with PharmaMar|language=en|work=Reuters|url=https://www.reuters.com/article/idUSFWN0W004R20150226|access-date=2023-03-14}}</ref> The company is listed on the Madrid Stock Exchange and is part of the IBEX 35.<ref>{{Cite web|title=I.G.B.M {{!}} Precios sesión Bolsa de Madrid|url=https://www.bolsasymercados.es/bme-exchange/es/Mercados-y-Cotizaciones/Acciones/Mercado-Continuo/Precios/igbm-ES0SI0000609|access-date=2023-03-14|website=BME Exchange|language=es}}</ref> It was founded in 1986. == References == <references /> [[Category:1986 establishments in Europe]] [[Category:1980s establishments in Spain]] [[Category:Manufacturing companies of Spain]] [[Category:Pharmaceutical companies of Europe]]